Patents Assigned to TRx Biosciences Limited
  • Compositions Having Improved Bioavailability of Therapeutics
    Publication number: 20240075147
    Abstract: The present specification discloses pharmaceutical composition disclosed herein comprises one or more therapeutic compounds, one or more glycerolipids, and one or more digestion enhancers. The disclosed glycerolipids comprise one or more hard fats and one or more liquid fats. The disclosed digestion enhancers comprise one or more bile acids, one or more phospholipids, one or more free C14-24 fatty acids, one or more free C14-24 fatty acid surfactants, or any combination thereof. The present specification also discloses methods and procedures to formulate the disclosed one or more therapeutic compounds into the disclosed pharmaceutical compositions.
    Type: Application
    Filed: October 16, 2023
    Publication date: March 7, 2024
    Applicant: TRx Biosciences Limited
    Inventors: John Brew, Daniel Gooding, Robin M. Bannister
  • Compositions Having Improved Bioavailability of Therapeutics
    Publication number: 20220305125
    Abstract: The present specification discloses pharmaceutical composition disclosed herein comprises one or more therapeutic compounds, one or more glycerolipids, and one or more digestion enhancers. The disclosed glycerolipids comprise one or more hard fats and one or more liquid fats. The disclosed digestion enhancers comprise one or more bile acids, one or more phospholipids, one or more free C14-24 fatty acids, one or more free C14-24 fatty acid surfactants, or any combination thereof. The present specification also discloses methods and procedures to formulate the disclosed one or more therapeutic compounds into the disclosed pharmaceutical compositions.
    Type: Application
    Filed: March 28, 2022
    Publication date: September 29, 2022
    Applicant: TRx Biosciences Limited
    Inventors: John Brew, Daniel Gooding, Robin M. Bannister